ClinicalTrials.gov
ClinicalTrials.gov Menu

Prospective Evaluation of Idiopathic Pancreatitis: Role of Endoscopic Ultrasonography

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00609726
Recruitment Status : Completed
First Posted : February 7, 2008
Last Update Posted : January 25, 2016
Sponsor:
Information provided by (Responsible Party):
University of Alabama at Birmingham

Brief Summary:
The purpose of the study is to determine the best evaluation for patients with idiopathic (unexplained) pancreatitis.

Condition or disease
Gallbladder Disease Pancreatitis

Detailed Description:
The study evaluates the role of endoscopic ultrasonography, given that the minimally invasive procedures can diagnosis gallbladder disease as well as pancreatitis abnormalities.

Study Type : Observational
Actual Enrollment : 199 participants
Observational Model: Case Control
Time Perspective: Prospective
Official Title: Prospective Evaluation of Idiopathic Pancreatitis: Role of Endoscopic Ultrasonography
Study Start Date : December 2015
Actual Primary Completion Date : December 2015
Actual Study Completion Date : December 2015

Resource links provided by the National Library of Medicine





Primary Outcome Measures :
  1. Evaluation of current clinical practice for patients with idiopathic pancreatitis [ Time Frame: 3 hours ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   19 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Men and women diagnosed with unexplained pancreatitis.
Criteria

Inclusion Criteria:

  • All patients referred to the principal investigator for unexplained pancreatitis will be enrolled.

Exclusion Criteria:

  • There are no gender nor racial exclusion.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00609726


Locations
United States, Alabama
University of Alabama
Birmingham, Alabama, United States, 35294
Sponsors and Collaborators
University of Alabama at Birmingham
Investigators
Principal Investigator: Charles M Wilcox, M.D. University of Alabama at Birmingham

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: University of Alabama at Birmingham
ClinicalTrials.gov Identifier: NCT00609726     History of Changes
Other Study ID Numbers: X040909004
228552 ( Other Identifier: Institutional OGCA Reference Number )
First Posted: February 7, 2008    Key Record Dates
Last Update Posted: January 25, 2016
Last Verified: January 2015

Keywords provided by University of Alabama at Birmingham:
Endoscopic Ultrasonography
Pancreatitis
EUS

Additional relevant MeSH terms:
Pancreatitis
Gallbladder Diseases
Pancreatic Diseases
Digestive System Diseases
Biliary Tract Diseases